Atrial Cardiomyopathy: Pathophysiology and Clinical Consequences

Andreas Goette1,2, Uwe Lendeckel3

  • 1Department of Cardiology and Intensive Care Medicine, St. Vincenz Hospital, 33098 Paderborn, Germany.

Cells
|October 23, 2021
PubMed

Insights

Atrial fibrillation (AF) affects millions globally, often linked to atrial cardiomyopathy. Understanding AF pathophysiology, including oxidative stress, inflammation, diabetes, and obesity, is key to preventing strokes.

Area of Science:

  • Cardiology
  • Pathophysiology
  • Biomedical Science

Background:

  • Atrial fibrillation (AF) impacts over 33.5 million people worldwide, with 5 million new cases annually.
  • Most AF patients exhibit atrial cardiomyopathy, a condition conceptualized in 2016.
  • Therapeutic strategies targeting underlying diseases and atrial tissue remodeling are crucial for AF management.

Purpose of the Study:

  • To summarize the pathophysiology and remodeling processes in atrial cardiomyopathy, thrombogenesis, and AF.
  • To elucidate the specific roles of oxidative stress, inflammation, diabetes, and obesity in AF development.

Main Methods:

  • Literature review and synthesis of existing research on atrial cardiomyopathy.
  • Analysis of pathophysiological mechanisms contributing to AF and thrombogenesis.
  • Focus on the impact of metabolic and inflammatory factors.

Main Results:

  • Atrial cardiomyopathy is a significant factor in AF, involving complex remodeling processes.
  • Oxidative stress, inflammation, diabetes, and obesity are identified as key contributors to AF pathophysiology.
  • Interventions addressing these factors may reduce thrombogenesis and stroke risk.

Conclusions:

  • Effective AF therapy requires addressing underlying atrial cardiomyopathy and associated risk factors.
  • Targeting oxidative stress, inflammation, diabetes, and obesity holds therapeutic potential for AF and stroke prevention.
  • Further research into these mechanisms can guide novel treatment strategies.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
94
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
123
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
73
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.0K
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
64
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
65